VITRAKVI Trademark

Trademark Overview

On Monday, March 5, 2018, a trademark application was filed for VITRAKVI with the United States Patent and Trademark Office. The USPTO has given the VITRAKVI trademark a serial number of 87819990. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, February 14, 2025. This trademark is owned by Bayer Aktiengesellschaft. The VITRAKVI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
vitrakvi

General Information

Serial Number87819990
Word MarkVITRAKVI
Filing DateMonday, March 5, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, February 14, 2025
Registration Number5584983
Registration DateTuesday, October 16, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 31, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, March 10, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBayer Aktiengesellschaft
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressLeverkusen 51373
DE
Party NameBayer Aktiengesellschaft
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
Address51373 Leverkusen
DE
Party NameBayer Aktiengesellschaft
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
Address51373 Leverkusen
DE

Trademark Events

Event DateEvent Description
Thursday, March 8, 2018NEW APPLICATION ENTERED
Saturday, March 10, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 9, 2018ASSIGNED TO EXAMINER
Wednesday, May 9, 2018SUSPENSION LETTER WRITTEN
Wednesday, May 9, 2018LETTER OF SUSPENSION E-MAILED
Wednesday, May 9, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, June 5, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, June 18, 2018ASSIGNED TO LIE
Wednesday, June 20, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 20, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 20, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 31, 2018PUBLISHED FOR OPPOSITION
Tuesday, July 31, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 16, 2018REGISTERED-PRINCIPAL REGISTER
Monday, October 16, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, October 2, 2024TEAS SECTION 8 & 15 RECEIVED
Tuesday, December 17, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 17, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 17, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 11, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, February 14, 2025POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
Friday, February 14, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, February 14, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, March 12, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 12, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 12, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 12, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 12, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED

Related Keywords

vitrakvi cancer treatment preparations pharmaceutical